SIMIONI, Carolina
 Distribuzione geografica
Continente #
NA - Nord America 4.610
AS - Asia 2.563
EU - Europa 2.038
SA - Sud America 416
Continente sconosciuto - Info sul continente non disponibili 164
AF - Africa 52
OC - Oceania 9
Totale 9.852
Nazione #
US - Stati Uniti d'America 4.454
SG - Singapore 971
CN - Cina 582
IT - Italia 564
PL - Polonia 519
BR - Brasile 330
VN - Vietnam 299
DE - Germania 233
HK - Hong Kong 187
GB - Regno Unito 129
UA - Ucraina 126
TR - Turchia 95
FI - Finlandia 94
FR - Francia 90
BD - Bangladesh 89
CA - Canada 89
IN - India 78
SE - Svezia 74
JP - Giappone 71
RU - Federazione Russa 65
ID - Indonesia 58
MX - Messico 50
AR - Argentina 35
NL - Olanda 34
PK - Pakistan 24
IQ - Iraq 23
ZA - Sudafrica 21
ES - Italia 19
BE - Belgio 18
CO - Colombia 16
AT - Austria 12
EC - Ecuador 10
MY - Malesia 10
VE - Venezuela 9
AL - Albania 8
AU - Australia 8
IE - Irlanda 8
LT - Lituania 8
UZ - Uzbekistan 8
HU - Ungheria 7
KE - Kenya 7
PH - Filippine 7
CH - Svizzera 6
CZ - Repubblica Ceca 6
JO - Giordania 6
NP - Nepal 6
PY - Paraguay 6
SA - Arabia Saudita 6
AE - Emirati Arabi Uniti 5
CL - Cile 5
DZ - Algeria 5
IR - Iran 5
MA - Marocco 5
EG - Egitto 4
TW - Taiwan 4
AZ - Azerbaigian 3
BH - Bahrain 3
BO - Bolivia 3
CG - Congo 3
HR - Croazia 3
IL - Israele 3
JM - Giamaica 3
KR - Corea 3
LB - Libano 3
SN - Senegal 3
TN - Tunisia 3
TT - Trinidad e Tobago 3
CR - Costa Rica 2
CY - Cipro 2
DO - Repubblica Dominicana 2
EU - Europa 2
KG - Kirghizistan 2
KW - Kuwait 2
LU - Lussemburgo 2
OM - Oman 2
RO - Romania 2
RS - Serbia 2
SI - Slovenia 2
SV - El Salvador 2
AM - Armenia 1
BG - Bulgaria 1
CW - ???statistics.table.value.countryCode.CW??? 1
GE - Georgia 1
GP - Guadalupe 1
GR - Grecia 1
GY - Guiana 1
HN - Honduras 1
IM - Isola di Man 1
IS - Islanda 1
KH - Cambogia 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LV - Lettonia 1
MD - Moldavia 1
MQ - Martinica 1
NI - Nicaragua 1
PS - Palestinian Territory 1
PT - Portogallo 1
ST - Sao Tome e Principe 1
TC - Turks e Caicos 1
Totale 9.689
Città #
Singapore 603
Ashburn 546
Warsaw 517
San Jose 397
Fairfield 383
Woodbridge 280
Houston 225
Santa Clara 189
Beijing 182
Ferrara 177
Hong Kong 177
Chandler 172
Seattle 158
Ann Arbor 156
Cambridge 144
Wilmington 140
Jacksonville 130
Council Bluffs 123
Dallas 103
Los Angeles 90
Ho Chi Minh City 88
Milan 88
New York 80
Hanoi 72
Tokyo 67
Munich 66
Izmir 55
Princeton 50
Helsinki 48
Nanjing 48
Jakarta 47
Lauterbourg 45
Shanghai 43
São Paulo 32
Bologna 31
San Diego 31
Boardman 27
Frankfurt am Main 27
Buffalo 24
Dearborn 24
Dong Ket 24
Mexico City 24
Montreal 22
Atlanta 20
Turku 19
Brussels 18
Nanchang 18
Orem 18
Phoenix 18
Shenyang 18
Hefei 17
Rome 17
Denver 16
Falkenstein 16
London 16
Toronto 16
Chennai 15
Chicago 15
San Francisco 15
Rio de Janeiro 14
Bengaluru 13
Da Nang 13
Boston 12
Montréal 12
Poplar 12
Stockholm 12
Baghdad 11
Changsha 11
Guangzhou 11
Haiphong 11
Auburn Hills 10
Brooklyn 10
Johannesburg 10
Paris 10
Amsterdam 9
Brasília 9
Columbus 9
Kunming 9
Moscow 9
Nuremberg 9
Belo Horizonte 8
Curitiba 8
Hebei 8
Hải Dương 8
Jinan 8
Lahore 8
Manchester 8
Miami 8
Ankara 7
Bremen 7
Bắc Ninh 7
Dhaka 7
Dublin 7
Hangzhou 7
Mumbai 7
Porto Alegre 7
Redwood City 7
Tashkent 7
Tianjin 7
Zhengzhou 7
Totale 6.601
Nome #
Cell cycle block by p53 acrivation reduces SARS-COV-2 release in infected alveolar basal epithelial A549-hACE2 cells 353
Targeting mTOR in Acute Lymphoblastic Leukemia 296
PI3K isoform inhibition associated with anti Bcr-Abl drugs shows in vitro increased anti-leukemic activity in Philadelphia chromosome-positive B-acute lymphoblastic leukemia cell lines 293
Healthy CD4+ T lymphocytes are not affected by targeted therapies against the PI3K/Akt/mTOR pathway in T-cell acute lymphoblastic leukemia 286
Cell cycle block by p53 activation reduces SARS-CoV-2 release in infected alveolar basal epithelial A549-hACE2 cells 284
PHARMACOLOGICAL CHARACTERIZATION OF THE SIGNAL TRANSDUCTION PATHWAYS MODULATED BY A3 RECEPTORS IN CANCER CELLS: POSSIBLE TARGETS FOR THERAPEUTIC INTERVENTION. 282
miR-199a-3p Modulates MTOR and PAK4 Pathways and Inhibits Tumor Growth in a Hepatocellular Carcinoma Transgenic Mouse Model 269
Synergistic effects of selective inhibitors targeting the PI3K/AKT/mTOR pathway or NUP214-ABL1 fusion protein in human Acute Lymphoblastic Leukemia 260
The novel dual PI3K/mTOR inhibitor NVP-BGT226 displays cytotoxic activity in both normoxic and hypoxic hepatocarcinoma cells 259
miRNAs as Influencers of Cell-Cell Communication in Tumor Microenvironment 256
Triple Akt inhibition as a new therapeutic strategy in T-cell acute lymphoblastic leukemia 255
Oxidative stress: role of physical exercise and antioxidant nutraceuticals in adulthood and aging 246
Targeting the phosphatidylinositol 3-kinase/Akt/mechanistic target of rapamycin signaling pathway in B-lineage acute lymphoblastic leukemia: An update 241
Physical training interventions for children and teenagers affected by acute lymphoblastic leukemia and related treatment impairments 238
Adenosine modulates vascular endothelial growth factor expression via hypoxiainducible factor-1 in human glioblastoma cells. 231
Adenosine receptors and cancer 231
M3 muscarinic receptors in peripheral lung parenchima of patients with chronic obstructive pulmonary disease. 215
SARS-CoV-2 nucleocapsid-protein and ultrastructural modifications in small bowel of a four week negative COVID-19 patient 201
Targeting the PI3K/Akt/mTOR signaling pathway in B-precursor acute lymphoblastic leukemia and its therapeutic potential 200
Pharmacological characterization of adenosine receptors in bovine chondrocytes. 199
Phosphatidylinositol 3-kinase inhibition potentiates glucocorticoid response in B-cell acute lymphoblastic leukemia 197
Optical tissue clearing associated with 3D imaging: application in preclinical and clinical studies 197
Binding thermodynamics at the human cannabinoid CB1 and CB2 receptors 195
Caffeine inhibits adenosine-induced accumulation of hypoxia-inducible factor-1α, vascular endothelial growth factor, and interleukin-8 expression in hypoxic human colon cancer cells 189
L'ipossia inibisce l'apoptosi indotta da paclitaxel mediante fosforilazione di BAD dipendente dall'adenosina nelle cellule di glioblastoma. 183
Cytotoxic drugs regulate VEGF and IL-8 expression in human melanoma cells by A2A and A3 adenosine receptors. 180
A3 ADENOSINE RECEPTORS MODULATE HYPOXIA-INDUCIBLE FACTOR-1ALPHA EXPRESSION IN HUMAN CANCER CELLS 177
The Complexity of the Tumor Microenvironment and Its Role in Acute Lymphoblastic Leukemia: Implications for Therapies 173
Activity of the novel mTOR inhibitor Torin-2 in B-precursor acute lymphoblastic leukemia and its therapeutic potential to prevent AKT reactivation. 171
Legislation to limit the environmental plastic and microplastic pollution and their influence on human exposure 166
New biomarkers and therapeutic strategies in acute lymphoblastic leukemias: recent advances 165
PI3K/Akt/mTOR Pathway in Acute Lymphoblastic Leukemia Targeted Therapies 164
Relevance of VEGF and CD147 in different SARS-CoV-2 positive digestive tracts characterized by thrombotic damage 159
Micrornas patterns as potential tools for diagnostic and prognostic follow‐up in cancer survivorship 156
Binding thermodynamics at the human A2B adenosine receptor. 155
Activity of the novel mTOR inhibitor Torin-2 in B-precursor acute lymphoblastic leukemia and its therapeutic potential to prevent Akt reactivation. 144
Microalgae as a Nutraceutical Tool to Antagonize the Impairment of Redox Status Induced by SNPs: Implications on Insulin Resistance 140
The role of extracellular vesicles as shuttles of RNA and their clinical significance as biomarkers in hepatocellular carcinoma 140
Effects of SARS-COV-2 on molecules involved in vascularization and autophagy in placenta tissues 134
A2B AND A3 ADENOSINE RECEPTORS MODULATE VASCULAR ENDOTHELIAL GROWTH FACTOR AND INTERLEUKIN-8 EXPRESSION IN HUMAN MELANOMA CELLS TREATED WITH ETOPOSIDE AND DOXORUBICIN. 132
VEGF and IL-8 regulation by cytotoxic drugs in human melanoma cells: molecular mechanism modulated by A2B and A3 adenosine receptors 123
Two neuroendocrine G protein-coupled receptor molecules, somatostatin and melatonin: Physiology of signal transduction and therapeutic perspectives 121
Cytotoxic activity of the novel Akt inhibitor, MK-2206, in T-cell acute lymphoblastic leukemia. 118
null 112
The novel Akt inhibitor MK-2206, is cytotoxic in T-cell acute lymphoblastic leukemia: Therapeutic implications 110
The mTOR inhibitor, RAD001, displays higher cytotoxicity in leukemias with hyperactivated PI3K/AKT/mTOR pathway 106
Increase of VEGF and Fibronectin expression and ultrastructural alterations of intercellular junctions in a swab negative patient after SARS-COV-2 infection 104
The AKT Inhibitor MK-2206 is Cytotoxic in Hepatocarcinoma Cells Displaying Hyperphosphorylated AKT-1 and Synergizes with Conventional Chemotherapy 100
null 95
Therapeutic potential of the novel mTOR inhibitor Torin-2 to overcome AKT reactivation in B-precursor acute lymphoblastic leukemia (B-pre ALL). 93
null 86
null 86
null 84
Regulation of Second Messenger Systems and Intracellular Pathways. 78
Cytokines, Signaling and Epigenetic Mechanisms: Shaping the Acute Lymphoblastic Leukemia Microenvironment 24
Totale 9.852
Categoria #
all - tutte 43.236
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.568
Totale 44.804


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022414 0 35 21 4 36 36 13 35 15 47 55 117
2022/2023467 55 36 26 42 60 49 42 31 45 30 37 14
2023/2024299 28 35 22 6 15 29 19 22 5 10 15 93
2024/20251.414 39 47 115 74 180 125 93 71 223 135 162 150
2025/20263.974 428 126 306 449 520 303 468 202 359 462 233 118
2026/2027215 93 122 0 0 0 0 0 0 0 0 0 0
Totale 9.852